# PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease

> **NCT01759017** · — · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 8 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01759017
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01759017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01759017, "PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01759017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*